ArticleBlood cancer journal2022

Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy.

Jarrod Longcor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.